Global Top 11 Companies Accounted for 47% of total Lyme Disease Testing market (QYResearch, 2021)
According to the new market research report “Global Lyme Disease Testing Market Report 2023-2029”, published by QYResearch, the global Lyme Disease Testing market size is projected to reach USD 0.33 billion by 2029, at a CAGR of 6.2% during the forecast period.
Above data is based on report from QYResearch: Global Lyme Disease Testing Market Report 2023-2029 (firmenpresse) - Lyme disease is caused by the bacterium Borrelia burgdorferi and rarely, Borrelia mayonii. It is transmitted to humans through the bite of infected blacklegged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. Lyme disease is usually diagnosed by serology. RIPL uses a modified 2-tier testing approach. The initial screening test is a combined IgG and IgM ELISA that detects antibodies against 2 Borrelia burgdorferi antigens – VlsE1 and pepC10.
According to the new market research report “Global Lyme Disease Testing Market Report 2023-2029”, published by QYResearch, the global Lyme Disease Testing market size is projected to reach USD 0.33 billion by 2029, at a CAGR of 6.2% during the forecast period.
The global key manufacturers of Lyme Disease Testing include Quidel Corporation, Roche Holding AG, Fujirebio(H.U. Group Holdings), ZEUS Scientific, Thermo Fisher Scientific, IGeneX, Everlywell, Oxford Immunotec Global PLC(PerkinElmer), Bio-Rad Laboratories, BioMerieux, etc. In 2021, the global top five players had a share approximately 34.0% in terms of revenue.
About QYResearch
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 16 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.
Unternehmensinformation / Kurzprofil:
QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.
Datum: 22.05.2024 - 09:19 Uhr
Sprache: Deutsch
News-ID 2099282
Anzahl Zeichen: 2206
Kontakt-Informationen:
Stadt:
??????
Telefon: 13051817187
Kategorie:
Öffentlicher Dienst
Meldungsart: Produktinformation
Versandart: Veröffentlichung
Diese Pressemitteilung wurde bisher 221 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Global Top 11 Companies Accounted for 47% of total Lyme Disease Testing market (QYResearch, 2021)"
steht unter der journalistisch-redaktionellen Verantwortung von
QYResearch (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
